More than 2 million people around the world live with multiple sclerosis (MS), a chronic and often debilitating disease. A cure has not yet been discovered, and only six FDA-approved drugs exist to treat the disease today. For some, these drugs may slow the progression of the disease, but for many, they do nothing at all.
Fast Forward, a wholly owned subsidiary of the National Multiple Sclerosis Society, was established to speed treatments to people with MS, through an innovative approach:
- Accelerating commercial development of innovative MS research
- Funding MS drug discovery in biotechnology and pharmaceutical companies
- Ensuring a global perspective in identifying funding opportunities
NEWS UPDATE:
FAST FORWARD HIGHLIGHTS
on without effective treatment. Fast Forward takes a business approach to speeding development of treatments and seeking a cure for people living with MS. Read more about Fast Forward from President Tim Coetzee.
Fast Forward Brochure (PDF - for easier print/read)